Live news related to DBV TECHNOLOGIES stock (FR0010417345): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The stock of the French biotech company specializing in food allergies sharply declined this Thursday, April 2, bucking its remarkable yearly trend. D…
DBV Technologies saw a rise of 2.21% this Wednesday, reaching 3.705 euros, in a generally bullish Parisian market. The biotech company specializing in…
DBV Technologies has announced the filing of its Form 10-K with the U.S. Securities and Exchange Commission and its Universal Registration Document 20…
French biopharmaceutical company DBV Technologies closed the fiscal year 2025 with mixed signals: a financial stronghold with cash reserves multiplied…
DBV Technologies has announced its inclusion in the CAC Mid 60 and SBF 120 indexes following the annual review of the Euronext Paris indexes. This cha…
DBV Technologies shares saw a slight increase of 0.14% this Tuesday, March 17, 2026, trading at €3.465, after experiencing significant selling pressur…
DBV Technologies announces its participation in two investor conferences scheduled for March. The biopharmaceutical company will present its business …
DBV Technologies marked a significant progression this Thursday, March 5, with a share price at 4.04 euros, up 7.59% from the previous day. The biotec…
DBV Technologies announces that it will present additional data from the phase 3 VITESSE study on the VIASKIN® Peanut patch in children aged 4 to 7 at…
DBV Technologies announces the participation of its CEO at a major conference organized by Guggenheim Securities. This presentation is part of the bio…
